1-5 of 5
Candida Cristina Quarta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Tolerability of Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia Therapy in Patients with Light-Chain Amyloidosis: 24-Month Results of a Phase 2 Study

Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Richa Manwani, Chandrasekhar Udata, Juliana Ianus, John Tripptree, Julia Catini, Candida Cristina Quarta
Journal: Blood
Blood (2023) 142 (Supplement 1): 540.
https://doi.org/10.1182/blood-2023-186515
Published: 2023
Journal Articles

Evaluation of the Path to Diagnosis and Time to Treatment in Patients with Light-Chain Amyloidosis Using the Komodo Claims Database

Julia Catini, Quan Doan, Jennifer Evans, Andrew Rava, Thomas Defay, Guillermo Del Angel, Megan Teynor, Candida Cristina Quarta, Mathew S. Maurer, Isabelle Lousada
Journal: Blood
Blood (2022) 140 (Supplement 1): 4330–4331.
https://doi.org/10.1182/blood-2022-162694
Published: 2022
Journal Articles

1-Year Results from a Phase 2 Study to Determine Safety and Tolerability of Treating Patients with Light-Chain (AL) Amyloidosis with Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia

Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Mark Tulchinskiy, Chandrasekhar Udata, Girly Ramirez, Kate Szymaniak, Julia Catini, Candida Cristina Quarta
Journal: Blood
Blood (2022) 140 (Supplement 1): 10127–10128.
https://doi.org/10.1182/blood-2022-162597
Published: 2022
Journal Articles

C11-1F4 Binds and Promotes Clearance of Light Chain Fibrils By Phagocytosis

Sahar Esteghamat, Dhirender Ahlawat, Steve Raiker, Melissa Batonick, Candida Cristina Quarta, Sahar Usmani-Brown
Journal: Blood
Blood (2022) 140 (Supplement 1): 12442–12443.
https://doi.org/10.1182/blood-2022-159766
Published: 2022
Journal Articles

Cardiac Amyloid Reaching for Extended Survival (CARES): Study Design of Two Placebo-Controlled, Double-Blind, Randomized, International Phase 3 Trials Assessing Cael-101 in Patients with Mayo Stage Iiia or Stage IIIb AL Amyloidosis

Ashutosh D. Wechalekar, John Silowsky, Eileen Daniel, Mark Harnett, Michael Spector, Susan B. Sobolov, Candida Cristina Quarta, Michael R. Kurman, Mark Tulchinskiy, Amit Bhattacharyya, Michaela Liedtke
Journal: Blood
Blood (2021) 138 (Supplement 1): 1673.
https://doi.org/10.1182/blood-2021-152488
Published: 2021